Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma
Cell Biology and Toxicology · 2025
DOI: 10.1007/s10565-024-09949-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2025. Verfasst von Yingping Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chines…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemokine CCL3, Endoplasmic Reticulum Stress, Carcinoma, Squamous Cell. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study investigated ERS-related gene expressions in CESC, identifying two molecular subtypes, P1 and P2, and constructing a precise prognostic model based on these subtypes. TCGA's whole-genome expression profiles were used to recognize these subtypes through the ConsensusClusterPlus method, further refining prognostic models with univariate and Lasso Cox regression analyses validated by the GSE39001 dataset. The study analyzed the expression distribution of ERS marker genes within T cell subgroups using scRNA-seq data (GSE168652), highlighting T cell diversity. The critical role of the CCL3 gene in prognostic models was examined explicitly in CD8 + T cells from healthy individuals and CESC patients. Elevated CCL3 levels were observed in patients' CD8 + T cells compared to healthy controls. Functional experiments involving CCL3 knockdown and overexpression in HeLa and SiHa CESC cell lines were conducted to investigate its impact on cell proliferation, migration, and invasion. These findings were subsequently validated in a nude mouse model. The results demonstrated that suppressing CCL3 inhibited cell proliferation, migration, and invasion significantly, while its overexpression promoted these processes. In the mouse model, CCL3 silencing reduced tumor growth and decreased Ki-67 labeling within the tumor tissues, indicating the therapeutic potential of targeting CCL3 in CESC treatment, possibly through CD8 + T cell regulation. This study contributes new prognostic assessment tools and personalized treatment options for CESC patients, paving the way for more targeted therapies in CESC by discovering the CCL3 gene, presenting significant clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
- Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, Hangzhou, China.
- College of Basic Medical Science, Zhejiang Chinese Medical University, 548 Binwen Rd, Hangzhou, 310053, China.
- First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
- College of Basic Medical Science, Zhejiang Chinese Medical University, 548 Binwen Rd, Hangzhou, 310053, China. wengcp@163.com.
- Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, Hangzhou, China. wengcp@163.com.
Zitieren
APA
Zhu, Y., Xu, W., He, Y., Yang, W., Song, S., & Wen, C. (2025). Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09949-3
Vancouver
Zhu Y, Xu W, He Y, Yang W, Song S, Wen C. Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma. Cell Biology and Toxicology. 2025. doi:10.1007/s10565-024-09949-3
BibTeX
@article{Zhu2025,
author = {Zhu, Yingping and Xu, Wei and He, Yuanfang and Yang, Wenjuan and Song, Siyue and Wen, Chengping},
title = {Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma},
journal = {Cell Biology and Toxicology},
year = {2025},
doi = {10.1007/s10565-024-09949-3}
}
EUVIMED